Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticleOncology

N-(2-(Dimethylamino)Ethyl)-4-18F-Fluorobenzamide: A Novel Molecular Probe for High-Contrast PET Imaging of Malignant Melanoma

Ayoung Pyo, Hyeon Sik Kim, Hyung Seok Kim, Misun Yun, Dong-Yeon Kim and Jung-Joon Min
Journal of Nuclear Medicine July 2019, 60 (7) 924-929; DOI: https://doi.org/10.2967/jnumed.118.221416
Ayoung Pyo
1Department of Nuclear Medicine, Chonnam National University Medical School and Hwasun Hospital, Hwasun, Korea
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hyeon Sik Kim
1Department of Nuclear Medicine, Chonnam National University Medical School and Hwasun Hospital, Hwasun, Korea
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hyung Seok Kim
2Department of Forensic Medicine, Chonnam National University Medical School, Hwasun, Korea; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Misun Yun
3Microbiology and Functionality Research Group, Research and Development Division, World Institute of Kimchi, Gwangju, Korea
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dong-Yeon Kim
1Department of Nuclear Medicine, Chonnam National University Medical School and Hwasun Hospital, Hwasun, Korea
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jung-Joon Min
1Department of Nuclear Medicine, Chonnam National University Medical School and Hwasun Hospital, Hwasun, Korea
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Additional Files
  • FIGURE 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 1.

    Chemical structure of 18F-DMFB.

  • FIGURE 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 2.

    (A) In vitro binding of 18F-DMFB to 2 mg of melanin at 37°C for 10, 30, 60, and 120 min. (B) In vitro uptake of 18F-DMFB by B16F10 cells in presence and absence of l-tyrosine at 10, 30, and 60 min, including photograph of B16F10 cell pellets in absence (left) and presence (right) of l-tyrosine.

  • FIGURE 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 3.

    (A) PET images of mice bearing B16F10 at 10, 30, and 60 min after injection of 18F-DMFB. (B and C) PET images of mice bearing B16F10 and CT26 (B) and B16F10 and U87MG (C) at 60 min after injection of 18F-DMFB (white arrow, B16F10; yellow arrow, CT26; red arrow, U87MG).

  • FIGURE 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 4.

    (A and B) Maximum-intensity-projection (top) and transaxial (bottom) images of normal (A) and lung metastasis (B) model (C57BL/6) at 60 min after injection of 18F-DMFB. (C) Coronal PET image of B16F10 liver metastasis model (Foxn1nu) at 60 min after injection of 18F-DMFB.

  • FIGURE 5.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 5.

    (A) Photograph of B16F10 LN metastasis model. (B) PET, CT, and PET/CT images of B16F10 LN metastasis model at 60 min after injection of 18F-DMFB. (C) Photomicrographs of LN metastasis. (White arrows, LN metastasis region.)

  • FIGURE 6.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 6.

    PET imaging of 18F-FDG and 18F-DMFB in mouse models. (A) Coronal images in mice bearing B16F10 at 60 min after injection. (B) Maximum-intensity-projection (top) and transaxial (bottom) images of lung metastasis model at 60 min after injection. mets = metastases.

Tables

  • Figures
  • Additional Files
    • View popup
    TABLE 1

    Biodistribution of 18F-DMFB in Foxn1nu Mice Bearing B16F10 After Intravenous Injection

    Site10 min30 min60 min120 min
    Blood5.26 ± 1.023.20 ± 0.510.98 ± 0.260.16 ± 0.006
    Heart6.22 ± 0.913.07 ± 0.171.20 ± 0.380.20 ± 0.024
    Lung11.66 ± 2.914.57 ± 0.651.89 ± 0.630.33 ± 0.031
    Liver11.19 ± 0.625.76 ± 0.412.47 ± 1.050.45 ± 0.06
    Spleen13.19 ± 2.585.88 ± 0.832.23 ± 0.920.34 ± 0.12
    Stomach9.01 ± 4.516.49 ± 2.352.87 ± 0.290.82 ± 0.64
    Intestine12.54 ± 1.567.88 ± 0.822.65 ± 0.800.52 ± 0.09
    Kidney40.42 ± 14.6916.74 ± 4.915.08 ± 1.690.93 ± 0.29
    Pancreas10.03 ± 3.204.73 ± 0.621.77 ± 0.780.20 ± 0.05
    Muscle5.67 ± 0.603.36 ± 1.681.44 ± 0.110.34 ± 0.12
    Bone5.07 ± 0.382.40 ± 0.401.03 ± 0.470
    Brain6.84 ± 1.022.96 ± 0.611.21 ± 0.700.26 ± 0.08
    Skin7.73 ± 1.633.94 ± 1.731.96 ± 0.320.37 ± 0.07
    Eyes4.26 ± 0.502.79 ± 0.711.05 ± 0.070.04 ± 0.02
    Tumor9.24 ± 2.2310.80 ± 3.2713.00 ± 3.9010.59 ± 1.35
    • Data are %ID/g ± SD (n = 3/time point).

Additional Files

  • Figures
  • Tables
  • Supplemental Data

    Files in this Data Supplement:

    • Supplemental Data
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 60 (7)
Journal of Nuclear Medicine
Vol. 60, Issue 7
July 1, 2019
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
N-(2-(Dimethylamino)Ethyl)-4-18F-Fluorobenzamide: A Novel Molecular Probe for High-Contrast PET Imaging of Malignant Melanoma
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
N-(2-(Dimethylamino)Ethyl)-4-18F-Fluorobenzamide: A Novel Molecular Probe for High-Contrast PET Imaging of Malignant Melanoma
Ayoung Pyo, Hyeon Sik Kim, Hyung Seok Kim, Misun Yun, Dong-Yeon Kim, Jung-Joon Min
Journal of Nuclear Medicine Jul 2019, 60 (7) 924-929; DOI: 10.2967/jnumed.118.221416

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
N-(2-(Dimethylamino)Ethyl)-4-18F-Fluorobenzamide: A Novel Molecular Probe for High-Contrast PET Imaging of Malignant Melanoma
Ayoung Pyo, Hyeon Sik Kim, Hyung Seok Kim, Misun Yun, Dong-Yeon Kim, Jung-Joon Min
Journal of Nuclear Medicine Jul 2019, 60 (7) 924-929; DOI: 10.2967/jnumed.118.221416
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • DISCLOSURE
    • Acknowledgments
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF

Related Articles

  • This Month in JNM
  • PubMed
  • Google Scholar

Cited By...

  • Melanin-Targeting Radiotracers and Their Preclinical, Translational, and Clinical Status: From Past to Future
  • Ultrasensitive detection of malignant melanoma using PET molecular imaging probes
  • Google Scholar

More in this TOC Section

Oncology

  • The diagnostic role of 68Ga-DOTATATE PET/CT in the detection of neuroendocrine tumors
  • Utility of bone scans in patients with RCC
  • Disseminated xanthogranulomatous oophoritis mimicking malignancy on 18F-fluorodeoxyglucose positron emission tomography/computed tomography
Show more Oncology

Basic

  • Dopamine D1 Receptor Agonist PET Tracer Development: Assessment in Nonhuman Primates
  • Optical Navigation of the Drop-In γ-Probe as a Means to Strengthen the Connection Between Robot-Assisted and Radioguided Surgery
  • Synthesis and Preclinical Evaluation of a 68Ga-Labeled Adnectin, 68Ga-BMS-986192, as a PET Agent for Imaging PD-L1 Expression
Show more Basic

Similar Articles

Keywords

  • malignant melanoma
  • metastasis
  • 18F-labeled benzamide derivative
  • PET
  • Molecular imaging
SNMMI

© 2025 SNMMI

Powered by HighWire